NCT05532280View on ClinicalTrials.gov

Bioequivalence Study of Etoricoxib in Healthy Adult Subjects Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 28, 2020

Primary Completion Date

January 14, 2021

Study Completion Date

January 14, 2021

Conditions
Healthy Subjects
Interventions
DRUG

Etoricoxib 90 mg film coated tablet

an immediate-release tablet containing 90 mg of Etoricoxib

DRUG

Arcoxia 90 mg film coated tablet

an immediate-release tablet containing 90 mg of Etoricoxib

Trial Locations (1)

11835

Future Research Center (FRC), Cairo

All Listed Sponsors
lead

Future University in Egypt

OTHER

NCT05532280 - Bioequivalence Study of Etoricoxib in Healthy Adult Subjects Under Fasting Condition | Biotech Hunter | Biotech Hunter